ROBIN HOWARD W

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$112,700.00
Insider Sells Quantity
80
Insider Sells Sum
$141.87M

Insider Activity of ROBIN HOWARD W

According to the SEC Form 4 filings, ROBIN HOWARD W, being in a position of

  1. President & CEO at Nektar Therapeutics,
    оver the last 12 months, has bought 0 shares, and sold 203613 shares for $220,287,
    over all time since 2007-03-05, has bought 10000 shares for $112,700, and sold 7484758 shares for $141.87M.

The largest purchase of all time was on 2007-03-05 and amounted to 10000 shares of Nektar Therapeutics for $112,700.

The largest sale of all time was on 2014-11-25 and amounted to 934400 shares of Nektar Therapeutics for $14.31M.

Biography of ROBIN HOWARD W

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$220,2876100

Comparison of Insiders on Amount of Buys and Sells

2025-02-19SaleNektar Therapeutics
NKTR
President & CEO
23,774
0.0123%
$1.01$24,012-15.92%
2024-12-18SaleNektar Therapeutics
NKTR
President & CEO
85,035
0.0497%
$0.99$84,185-3.61%
2024-12-17SaleNektar Therapeutics
NKTR
President & CEO
46,995
0.0255%
$1.01$47,465-12.57%
2024-11-19SaleNektar Therapeutics
NKTR
President & CEO
16,278
0.0087%
$1.01$16,441-10.87%
2024-08-19SaleNektar Therapeutics
NKTR
President & CEO
14,881
0.0078%
$1.28$19,048-19.55%
2024-05-17SaleNektar Therapeutics
NKTR
President & CEO
16,650
0.0087%
$1.75$29,138-32.95%
2024-02-20SaleNektar Therapeutics
NKTR
President & CEO
20,033
0.0107%
$0.68$13,622+82.34%
2023-11-17SaleNektar Therapeutics
NKTR
President & CEO
19,877
0.0105%
$0.49$9,740+153.13%
2023-08-16SaleNektar Therapeutics
NKTR
President & CEO
19,998
0.0107%
$0.78$15,598-7.79%
2023-05-16SaleNektar Therapeutics
NKTR
President & CEO
20,361
0.0109%
$0.72$14,660-18.26%
2023-02-16SaleNektar Therapeutics
NKTR
President & CEO
19,635
0.0106%
$3.00$58,905-80.3%
2022-11-16SaleNektar Therapeutics
NKTR
President & CEO
38,014
0.0205%
$3.57$135,710-79.26%
2022-08-15SaleNektar Therapeutics
NKTR
President & CEO
13,759
0.0071%
$4.76$65,493-53.97%
2022-05-15SaleNektar Therapeutics
NKTR
President & CEO
36,529
0.0194%
$3.95$144,290-16.49%
2022-02-16SaleNektar Therapeutics
NKTR
President & CEO
12,480
0.0066%
$10.95$136,656-66.85%
2021-11-16SaleNektar Therapeutics
NKTR
President & CEO
42,773
0.0231%
$13.16$562,893-66.33%
2021-08-16SaleNektar Therapeutics
NKTR
President & CEO
11,515
0.0063%
$13.83$159,252-22.59%
2021-05-17SaleNektar Therapeutics
NKTR
President & CEO
11,560
0.0064%
$18.30$211,548-24.57%
2021-02-16SaleNektar Therapeutics
NKTR
President & CEO
11,495
0.0063%
$22.37$257,143-26.4%
2021-02-04SaleNektar Therapeutics
NKTR
President & CEO
150,000
0.0814%
$20.29$3.04M-19.08%
Total: 81
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.